These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 10499443

  • 1. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes.
    Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF.
    J Neuropathol Exp Neurol; 1999 Sep; 58(9):1010-9. PubMed ID: 10499443
    [Abstract] [Full Text] [Related]

  • 2. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
    Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP.
    Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
    [Abstract] [Full Text] [Related]

  • 3. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
    Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo JM, Hanger D, Mulot S, Marquardt B, Stabel S.
    Curr Biol; 1994 Dec 01; 4(12):1077-86. PubMed ID: 7704571
    [Abstract] [Full Text] [Related]

  • 4. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I, Barrachina M, Puig B.
    Acta Neuropathol; 2002 Dec 01; 104(6):583-91. PubMed ID: 12410379
    [Abstract] [Full Text] [Related]

  • 5. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.
    Leroy K, Yilmaz Z, Brion JP.
    Neuropathol Appl Neurobiol; 2007 Feb 01; 33(1):43-55. PubMed ID: 17239007
    [Abstract] [Full Text] [Related]

  • 6. Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter.
    Lau KF, Miller CC, Anderton BH, Shaw PC.
    Genomics; 1999 Sep 01; 60(2):121-8. PubMed ID: 10486203
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation.
    Elyaman W, Terro F, Wong NS, Hugon J.
    Eur J Neurosci; 2002 Feb 01; 15(4):651-60. PubMed ID: 11886446
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
    An WL, Cowburn RF, Li L, Braak H, Alafuzoff I, Iqbal K, Iqbal IG, Winblad B, Pei JJ.
    Am J Pathol; 2003 Aug 01; 163(2):591-607. PubMed ID: 12875979
    [Abstract] [Full Text] [Related]

  • 11. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain.
    Pei JJ, Tanaka T, Tung YC, Braak E, Iqbal K, Grundke-Iqbal I.
    J Neuropathol Exp Neurol; 1997 Jan 01; 56(1):70-8. PubMed ID: 8990130
    [Abstract] [Full Text] [Related]

  • 12. Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation.
    Baum L, Hansen L, Masliah E, Saitoh T.
    Mol Chem Neuropathol; 1996 Jan 01; 29(2-3):253-61. PubMed ID: 8971700
    [Abstract] [Full Text] [Related]

  • 13. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration.
    Pei JJ, Braak H, Gong CX, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF.
    Acta Neuropathol; 2002 Oct 01; 104(4):369-76. PubMed ID: 12200623
    [Abstract] [Full Text] [Related]

  • 14. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
    Ferrer I, Barrachina M, Tolnay M, Rey MJ, Vidal N, Carmona M, Blanco R, Puig B.
    Brain Pathol; 2003 Jan 01; 13(1):62-78. PubMed ID: 12580546
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
    Iqbal K, Alonso AC, Gong CX, Khatoon S, Pei JJ, Wang JZ, Grundke-Iqbal I.
    J Neural Transm Suppl; 1998 Jan 01; 53():169-80. PubMed ID: 9700655
    [Abstract] [Full Text] [Related]

  • 16. GSK-3 is essential in the pathogenesis of Alzheimer's disease.
    Takashima A.
    J Alzheimers Dis; 2006 Jan 01; 9(3 Suppl):309-17. PubMed ID: 16914869
    [Abstract] [Full Text] [Related]

  • 17. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta.
    Isagawa T, Mukai H, Oishi K, Taniguchi T, Hasegawa H, Kawamata T, Tanaka C, Ono Y.
    Biochem Biophys Res Commun; 2000 Jun 24; 273(1):209-12. PubMed ID: 10873588
    [Abstract] [Full Text] [Related]

  • 18. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
    Zheng-Fischhöfer Q, Biernat J, Mandelkow EM, Illenberger S, Godemann R, Mandelkow E.
    Eur J Biochem; 1998 Mar 15; 252(3):542-52. PubMed ID: 9546672
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.